Tag
MIT Technology Review features five young innovators under 35 working on groundbreaking biotech projects, including a postpartum hemorrhage device, advanced brain electrodes, personalized gene-editing therapy, age-reversal eye treatment, and AI-designed viruses.
A geneticist developing age-reversal techniques for vision has seen his research advance to human clinical trials, with a treatment already administered to a patient with glaucoma.
In a new interview, Dr. Derya Unutmaz predicts that longevity escape velocity will arrive within 8–10 years, potentially extending lifespan by 50 years, and that cancer will be 100% curable in less than a decade.